Qualitative Research Study accomplished by Stratagem Market Insights research s database of 350 pages titled Global Digital Therapeutics DTx Market Study with 100 market data Tables Pie Charts Graphs Figures spread through Pages and easy to understand detailed analysis The ...
Addressing mental health is the “missing puzzle piece” for acquirers across healthcare, making industry startups attractive targets, analysts say.
InsiderDarioHealth Corp. (NASDAQ: DRIO) recently announced
PR Newswire/PRNewswire/ -- DelveInsight’s ‘Major Depressive Disorder Pipeline Insight 2022’ report provides comprehensive global coverage of available, marketed, and...
PR NewswireAs SPACs grow out of favor, the ADHD-focused digital therapeutics company secures a fully committed PIPE of $163M-plus.
BenzingaGainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday’s after-market session. The company’s market cap stands at $31.6 million.
BenzingaAs SPACs grow out of favor, the ADHD-focused digital therapeutics company secures a fully committed PIPE of $163M-plus.
BenzingaLOS ANGELES--(BUSINESS WIRE)--Aug 22, 2022--
BenzingaGainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday’s after-market session. The company’s market cap stands at $31.6 million.
BenzingaPear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) major shareholder 5Am Partners Iv, Llc sold 167,162 shares of the firm’s stock in a transaction that occurred on Tuesday, August 16th. The shares were sold at an average price of $1.78, for a total value of $297,548.36. Following the completion of t…
Insider IntelligencePear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) – Lifesci Capital lowered their Q3 2022 earnings estimates for shares of Pear Therapeutics in a note issued to investors on Tuesday, August 16th. Lifesci Capital analyst R. Rakhit now anticipates that the company will post earnings per share of ($0.…
Insider IntelligenceMost Medicare Advantage plans fall short on substance abuse disorder coverage Insider Intelligence
Most Medicare Advantage plans fall short on substance abuse disorder coverage Insider Intelligence
New York, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Digital Therapeutics Market by Application ; By End Use ; By Type, and Region – Analysis of Market Size,
openPR<p>Speaking to <em>Medtech Insight</em>, Sequana Medical’s CEO discussed the company’s two technologies for combating fluid overload whilst explaining that, sometimes, chasing approval as a drug can be the best way to ensure easy market access.</p>
openPRA Latest intelligence report published by Data Bridge Market Research with title Prescription Digital Therapeutics PDTx Market Outlook Companies Regions Type And Application and Forecast to 2029 A detailed study accumulated offers a complete overview of various key elements impacting ...
The layoffs represent 13% of the AI-backed genomic and clinical data company’s workforce.
Pear Announces Publication of New Analysis of Real-World Data in Adults Using Somryst®
Democratic Georgia gubernatorial candidate Stacey Abrams has COVID-19. Abrams campaign spokesperson Alex Floyd says Abrams tested positive for the respiratory illness Wednesday morning after giving a public speech on the
